Mouse IgA isotype control [S107]
Cat# GTX35045-100μg
Size : 100μg
Marca : GeneTex
Host | Mouse |
---|---|
Clonality | Monoclonal |
Clone Name | S107 |
Isotype | IgA |
Application | FACS, ELISA |
Package | 100 μg |
View product citations for antibody GTX35045 on CiteAb
APPLICATION
Application Note
Use at a concentration/dilution equivalent to that of your experimental primary antibody.
Product Note
Unknown
PROPERTIES
Form
Liquid
Buffer
Borate buffered saline
Preservative
No preservative
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC.
Concentration
1 mg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
Mouse IgA kappa negative control , Mouse IgA negative control , Mouse IgA kappa isotype control , Mouse negative control for IgA kappa , monoclonal Mouse IgA isotype control , Negative control for Mouse IgA kappa , Isotype cont , Mouse IgA isotype control
Background
Inclusion of an appropriate isotype control is essential for the proper interpretation of experimental results. Because isotype control antibodies have no relevant specificity, they enable the researcher to distinguish non-specific "background" binding from antigen-specific antibody binding. Non-specific binding of primary antibodies may occur due to either binding of antibody to Fc receptors or non-specific interactions with cellular proteins, lipids, or carbohydrates. Additionally, autofluorescence or endogenous enzyme activity in target cells may give a false positive that could be misinterpreted as antibody binding. These factors vary by target cell type and the isotype of the primary antibody. Therefore, the primary antibody used should be matched to an isotype control of identical species and isotype (including both heavy and light chains).
Application Reference
Fernandes RC et al. Cell Rep 2021; 34 (1) : 108585 Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
Rayzel C. Fernandes et al. bioRxiv 2019; (Epub) MicroRNA-194 promotes lineage plasticity in advanced prostate cancer.
Chang R et al. Biomed Res Int 2016; 2016 : 9576503
REVIEW
Application Reference
Fernandes RC et al. Cell Rep 2021; 34 (1):108585 Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
Rayzel C. Fernandes et al. bioRxiv 2019; (Epub) MicroRNA-194 promotes lineage plasticity in advanced prostate cancer.
Chang R et al. Biomed Res Int 2016; 2016:9576503